Liquid Biopsy in Cancer: Focus on Lymphoproliferative Disorders.

ABSTRACT: Within the context of precision medicine, the scientific community is giving particular attention to early diagnosis and intervention, guided by non-invasive methodologies. Liquid biopsy (LBx) is a recent laboratory approach consisting of a non-invasive blood draw, which allows the detection of information about potential prognostic factors, or markers to be used for diagnostic purposes; it might also allow the clinician to establish a treatment regimen and predict a patient's response. Since the discovery of circulating tumor cells (CTCs) in the nineteenth century, the possibility of integrating LBx into clinical practice has been explored, primarily because of its safeness and easy execution: indeed, compared to solid biopsy, sampling-related risks are less of a concern, and the quicknes

SUBMITTER: Savino FD 

PROVIDER: S-EPMC9654765 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature